Of note, antigen-specific regulatory T cells activated by therapeutics antagonizing TNF-α or GM-CSF have been shown play major immune suppressive roles in RA and other autoimmune diseases [48, 49]. This evidence concerns the gene TNF and rheumatoid arthritis.